The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation ...

Radiopharm Theranostic (RADX)s announced a poster presentation at EMIM 20251, with findings that support the clinical utility of imaging and ...

"We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said ...

Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...

Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are ...

Anemia and low performance status predict worse survival and greater risk for treatment failure in low-intermediate risk vs ...

A poster presentation often discusses research or an academic project using a poster that can be read and viewed by a large audience. The individual presenter(s) will use their posters to illustrate ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs ...

On February 12, 2025, the United States District Court for the District of Delaware denied defendant Parse Biosciences’s (“Parse”) motions for ...

She shared her results earlier this year during a RIT-Rochester Regional Health Alliance poster presentation held at ...